Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors

by Zainab Fatima, Abdulrahman Abonofal, Bettzy Stephen
Published 2023-05-01

A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma

by Chijioke Nze, Pavlos Msaouel, Mohamed H. Derbala, Bettzy Stephen, Abdulrahman Abonofal, Funda Meric-Bernstam, Nizar M. Tannir, Aung Naing
Published 2023-07-01

Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial

by Aung Naing, Funda Meric-Bernstam, Michael Overman, Bettzy Stephen, David S Hong, Sarina A Piha-Paul, Daniel D Karp, Kanwal P Raghav, Dipti Jain, Dilichukwu O Chudy Onwugaje, Abdulrahman Abonofal, Anneleis F Willett, Brandon Smaglo, Ryan W Huey, Gauri R Varadhachary
Published 2022-05-01